Homo- and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes. Differential regulation of beta-arrestins 1 and 2 - PubMed (original) (raw)

. 2002 Dec 27;277(52):50422-30.

doi: 10.1074/jbc.M209340200. Epub 2002 Oct 21.

Affiliations

• PMID: 12393857
• DOI: 10.1074/jbc.M209340200

Free article

Homo- and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes. Differential regulation of beta-arrestins 1 and 2

Aylin C Hanyaloglu et al. J Biol Chem. 2002.

Free article

Abstract

G-protein-coupled receptors (GPCRs) are regulated by a complex network of mechanisms such as oligomerization and internalization. Using the GPCR subtypes for thyrotropin-releasing hormone (TRHR1 and TRHR2), the aim of this study was to determine if subtype-specific differences exist in the trafficking process. If so, we wished to determine the impact of homo- and hetero-oligomerization on TRHR subtype trafficking as a potential mechanism for the differential cellular responses induced by TRH. Expression of either beta-arrestin 1 or 2 promoted TRHR1 internalization. In contrast, only beta-arrestin 2 could enhance TRHR2 internalization. The preference for beta-arrestin 2 by TRHR2 was supported by the impairment of TRHR2 trafficking in mouse embryonic fibroblasts (MEFs) from either a beta-arrestin 2 knockout or a beta-arrestin 1/2 knockout, while TRHR1 trafficking was only abolished in MEFs lacking both beta-arrestins. The differential beta-arrestin-dependence of TRHR2 was directly measured in live cells using bioluminescence resonance energy transfer (BRET). Both BRET and confocal microscopy were also used to demonstrate that TRHR subtypes form hetero-oligomers. In addition, these hetero-oligomers have altered internalization kinetics compared with the homo-oligomer. The formation of TRHR1/2 heteromeric complexes increased the interaction between TRHR2 and beta-arrestin 1. This may be due to conformational differences between TRHR1/2 hetero-oligomers versus TRHR2 homo-oligomers as a mutant TRHR1 (TRHR1 C335Stop) that does not interact with beta-arrestins, could also enhance TRHR2/beta-arrestin 1 interaction. This study demonstrates that TRHR subtypes are differentially regulated by the beta-arrestins and also provides the first evidence that the interactions of TRHRs with beta-arrestin may be altered by hetero-oligomer formation.

PubMed Disclaimer

Similar articles

• Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence resonance energy transfer.
  Kroeger KM, Hanyaloglu AC, Seeber RM, Miles LE, Eidne KA. Kroeger KM, et al. J Biol Chem. 2001 Apr 20;276(16):12736-43. doi: 10.1074/jbc.M011311200. Epub 2001 Jan 18. J Biol Chem. 2001. PMID: 11278883
• Beta-arrestin mediates desensitization and internalization but does not affect dephosphorylation of the thyrotropin-releasing hormone receptor.
  Jones BW, Hinkle PM. Jones BW, et al. J Biol Chem. 2005 Nov 18;280(46):38346-54. doi: 10.1074/jbc.M502918200. Epub 2005 Sep 23. J Biol Chem. 2005. PMID: 16183993
• Receptors for hypothalamic releasing hormones TRH and GnRH: oligomerization and interactions with intracellular proteins.
  Pfleger KD, Kroeger KM, Eidne KA. Pfleger KD, et al. Semin Cell Dev Biol. 2004 Jun;15(3):269-80. doi: 10.1016/j.semcdb.2003.12.016. Semin Cell Dev Biol. 2004. PMID: 15125890 Review.
• _β_-Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives.
  Wess J, Oteng AB, Rivera-Gonzalez O, Gurevich EV, Gurevich VV. Wess J, et al. Pharmacol Rev. 2023 Sep;75(5):854-884. doi: 10.1124/pharmrev.121.000302. Epub 2023 Apr 7. Pharmacol Rev. 2023. PMID: 37028945 Free PMC article. Review.

Cited by

• Desensitization, trafficking, and resensitization of the pituitary thyrotropin-releasing hormone receptor.
  Hinkle PM, Gehret AU, Jones BW. Hinkle PM, et al. Front Neurosci. 2012 Dec 13;6:180. doi: 10.3389/fnins.2012.00180. eCollection 2012. Front Neurosci. 2012. PMID: 23248581 Free PMC article.
• New technologies: bioluminescence resonance energy transfer (BRET) for the detection of real time interactions involving G-protein coupled receptors.
  Pfleger KD, Eidne KA. Pfleger KD, et al. Pituitary. 2003;6(3):141-51. doi: 10.1023/b:pitu.0000011175.41760.5d. Pituitary. 2003. PMID: 14974443 Review.
• A novel TRH analog, Glp-Asn-Pro-D-Tyr-D-TrpNH2, binds to [3H][3-Me-His2]TRH-labelled sites in rat hippocampus and cortex but not pituitary or heterologous cells expressing TRHR1 or TRHR2.
  Hogan N, O'Boyle KM, Hinkle PM, Kelly JA. Hogan N, et al. Neurosci Lett. 2008 Jan 24;431(1):26-30. doi: 10.1016/j.neulet.2007.11.013. Epub 2007 Nov 17. Neurosci Lett. 2008. PMID: 18069127 Free PMC article.
• Subcellular trafficking of the TRH receptor: effect of phosphorylation.
  Jones BW, Hinkle PM. Jones BW, et al. Mol Endocrinol. 2009 Sep;23(9):1466-78. doi: 10.1210/me.2009-0119. Epub 2009 Jun 18. Mol Endocrinol. 2009. PMID: 19541745 Free PMC article.
• Type-3 BRET, an improved competition-based bioluminescence resonance energy transfer assay.
  Felce JH, Knox RG, Davis SJ. Felce JH, et al. Biophys J. 2014 Jun 17;106(12):L41-3. doi: 10.1016/j.bpj.2014.04.061. Biophys J. 2014. PMID: 24940791 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database